Todd invests in early stage life sciences and medical technology companies for Longwall Ventures. She began venture investing in 2006 while at Oxford Capital, where she took responsibility for the Oxford Gateway Funds’ investments into healthcare and life sciences companies. She went on to become director of healthcare ventures at Imperial Innovations (now part of IP Group). Her earlier career was as a marketing consultant to pharmaceutical and life sciences technology companies. Todd has a PhD in Genetics from Nottingham University and an MBA from Oxford University. She joined Longwall Ventures in 2017.